Cliff Asness's PRCT Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 370,455 shares of PROCEPT BioRobotics Corporation (PRCT) worth $8.36 M, representing 0.00% of the portfolio. First purchased in 2024-Q2, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in PRCT, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 212,793 shares. Largest reduction occurred in Q4 2025, reducing 23,283 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's PROCEPT BioRobotics Corporation (PRCT) Holding Value Over Time
Track share changes against reported price movement
Quarterly PROCEPT BioRobotics Corporation (PRCT) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +114,604 | Add 44.79% | 370,455 | $22.58 |
| Q1 2026 | +212,793 | Add 494.20% | 255,851 | $25.01 |
| Q4 2025 | -23,283 | Reduce 35.10% | 43,058 | $31.46 |
| Q3 2025 | +12,887 | Add 24.11% | 66,341 | $35.69 |
| Q2 2025 | +34,562 | Add 182.95% | 53,454 | $57.60 |
| Q1 2025 | +1,286 | Add 7.30% | 18,892 | $58.26 |
| Q4 2024 | +8,590 | Add 95.28% | 17,606 | $80.52 |
| Q3 2024 | +3,877 | Add 75.44% | 9,016 | $80.12 |
| Q2 2024 | +5,139 | New Buy | 5,139 | $61.09 |
Cliff Asness's PROCEPT BioRobotics Corporation Investment FAQs
Cliff Asness first purchased PROCEPT BioRobotics Corporation (PRCT) in Q2 2024, acquiring 5,139 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held PROCEPT BioRobotics Corporation (PRCT) for 9 quarters since Q2 2024.
Cliff Asness's largest addition to PROCEPT BioRobotics Corporation (PRCT) was in Q1 2026, adding 255,851 shares worth $6.4 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 370,455 shares of PROCEPT BioRobotics Corporation (PRCT), valued at approximately $8.36 M.
As of the Q2 2026 filing, PROCEPT BioRobotics Corporation (PRCT) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in PROCEPT BioRobotics Corporation (PRCT) was 370,455 shares, as reported at the end of Q2 2026.